Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Sulfonamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108976178A reveals a safe, atmospheric Pd-catalyzed route for chiral sulfonamides. Discover cost-effective manufacturing and supply chain advantages.
Patent CN112898318A enables high-purity chiral polycyclic synthesis. Reduces heavy metal risks and improves supply chain reliability for pharma intermediates.
Novel axially chiral ligand enables high-yield asymmetric synthesis. Reduces costs and improves supply chain reliability for chiral aminoamide manufacturing.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN106866574A reveals palladium-catalyzed asymmetric reductive amination for high-purity chiral sulfonamides, offering supply chain reliability and cost efficiency.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN101569864B details a novel chiral sulfonamide catalyst enabling high-yield asymmetric conjugate addition, offering a metal-free alternative for pharmaceutical manufacturing.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Patent CN114276280B reveals enzymatic route for chiral sulfonamide. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.